Identity
- Method
- LC-MS
- Status
- Pass
Historical batch record
This report covers a past batch. The product page shows current availability.
Certificate of Analysis
Tesamorelin 10 mg
- Batch PSTES1071926GX
- Tested July 24, 2026
- Freedom Diagnostics Testing
Testing passed
Review the results and original report below. Match the batch number, cap and crimp with your vial.
Measured values
- Purity
- 99.89% Pass Purity measured by the laboratory.
- Measured content
- 12.09 mg ReportedContent measured during testing.
- Labeled content
- 10 mg Amount stated on the vial submitted for testing.
Testing overview
- IdentityPass
- PurityPass
- Measured contentMeasured
- SterilityPass
- Fentanyl screeningPass
Independent laboratory data
| Test | Laboratory evidence | Status |
|---|---|---|
| Identity |
| Pass |
| Purity |
| Pass |
| Measured content |
| Reported |
| Sterility |
| Pass |
| Fentanyl Screen |
| Pass |
Purity
- Method
- HPLC
- Result
- 99.89%
- Status
- Pass
Measured content
- Result
- 12.09 mg
- Status
- Reported
Sterility
- Result
- No growth detected
- Status
- Pass
Fentanyl Screen
- Method
- Immunoassay
- Specification
- Immunoassay, 50 ng/mL cutoff
- Result
- Not detected
- Status
- Pass
Original document
Certificate pages
Expand to view pages
Original document
Certificate pages
Source documentation
Laboratory Report
Original analysis from the independent laboratory.
Report details
- Laboratory
- Freedom Diagnostics Testing
- COA reference
- PepS2607210190
- Analysis date
- July 24, 2026
Freedom Diagnostics TestingIndependent Testing Laboratorycoas.freedomdiagnosticstesting.com
